Search results
Rubrik sets IPO price at $32 per share on $5.6B valuation ahead of NYSE debut - SiliconANGLE
SiliconANGLE· 19 hours agoData security software provider Rubrik Inc. today set an initial public offering price of $32 per ...
Why Whirlpool Stock Went Into a Downward Spiral Today
Motley Fool via Yahoo Finance· 58 minutes agoThe company also had ongoing earnings per share (EPS) of $1.78, which were down 33%, reflecting the...
IBM's Stock Got a Big, Blue Bruise Today
Motley Fool via Yahoo Finance· 1 hour agoMeanwhile, IBM is buying HashiCorp for $35 per share, an all-cash deal with an enterprise value of $6.4 billion. HashiCorp specializes in monitoring and...
Why Bristol Myers Squibb Stock Is Sinking Today
Motley Fool via Yahoo Finance· 4 hours agoThe decline in Bristol Myers Squibb's share price today wasn't because of its Q1 numbers. The company's revenue came in above...expected ...
AI Chip Leader Arm Stock Plunges 31%, Is It A Buy Right Now?
Investor's Business Daily· 1 hour agoIBD's proprietary Earnings Per Share Rating allows you to quickly identify stocks with the strongest...
Why Honeywell Stock Is Under Pressure Today
Motley Fool via Yahoo Finance· 1 hour agoHoneywell expects to earn between $2.25 and $2.35 per share in the current quarter, implying some potential downside to Wall Street...at current prices...
Why O'Reilly (ORLY) Shares Are Getting Obliterated Today By Stock Story
Investing.com· 4 hours agoAdditionally, the company's full-year earnings forecast was underwhelming. At the end of the...
Stock Market Today: Stocks tumble as GDP slows with inflation spike; Meta plunges
TheStreet via Yahoo Finance· 8 hours agoStock Market Today Meta (META) is likely to be the biggest driver of market action at the open, with...
Barclays Just Slashed Its Price Target on Li Auto (LI) Stock
InvestorPlace· 5 hours agostock is slipping on Thursday after the electric vehicle (EV) company’s shares were hit with a price...
Merck Stock Jumps After Dow Jones Stalwart Rides Its Cancer 'Star' To Another Quarterly Beat
Investor's Business Daily· 2 hours ago"We do not believe this positive outlook is reflected in the price of the shares." Cancer Drugs,...
